Glioma Therapy
Research from University of Erlangen yields new findings on glioma therapy
Published in Cancer Weekly, July 17th, 2007
Scientists discuss in "The peroxisome proliferator-activated receptor-gamma agonist troglitazone inhibits transforming growth factor-beta-mediated glioma cell migration and brain invasion" new findings in glioma. "Gliomas are the most common primary tumors of the central nervous system, with glioblastomas as the most malignant entity. Rapid proliferation and diffuse brain invasion of these tumors are likely to determine the unfavorable prognosis," scientists in Erlangen, Germany report.
"Considering its promigratory properties, the transforming growth factor-beta (TGF-beta) signaling pathway has become a major therapeutic target. Analyses of resected glioma tissues...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-07-17)
More Articles from Cancer Weekly
- Breast Cancer
Analysis confirms benefits of combining trastuzumab and chemotherapy - Cancer Gene Therapy
Turning stem cells taken from fat tissue into personalized, cancer-targeted therapeutics - Cancer Vaccines
From clinical cancer research: rethinking therapeutic cancer vaccine trials - Cancer Vaccines
Harnessing the power of the immune system to fight cancer - Cancer Vaccines
Human antibodies that block human and animal SARS viruses identified - Chronic Lymphocytic Leukemia
‘Modular’ Leukemia Drug Shows Promise in Early Testing - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
